Company news

Solana Company news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Helius Medical Technologies, Inc. Announces PoNS® Is Now Available on the Veterans Affairs (VA) Federal Supply Schedule (FSS) and General Services Administration (GSA) Advantage Contracts

May 19, 2024

Helius Medical Technologies, Inc. Reports First Quarter 2024 Financial Results

May 12, 2024

Helius Medical Technologies, Inc. to Release First Quarter 2024 Financial Results on May 13, 2024

May 9, 2024

Helius Medical Technologies, Inc. Announces Pricing of $6.4 Million Public Offering

May 5, 2024

Helius Medical Technologies, Inc. Announces Preliminary CMS Payment Determination of Reimbursement for Portable Neuromodulation Stimulator (PoNS®)

May 5, 2024

Helius Medical Technologies, Inc. Expands Stroke Clinical Program with Participation of Shepherd Center

April 23, 2024

Helius Medical Technologies, Inc. Announces Partnership with Lovell® Government Services to Expand Reach of PoNS Therapy™

April 2, 2024

Helius Medical Technologies, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results

March 27, 2024

Helius Medical Technologies, Inc. to Release Fourth Quarter and Full Year 2023 Financial Results on March 28, 2024

March 14, 2024

Helius Medical Technologies, Inc. Initiates Open-Label Study for Registrational Program in Stroke

March 11, 2024

Helius Medical Technologies, Inc. to Present at the 36th Annual ROTH Conference

March 6, 2024

Helius Medical Technologies, Inc. Secures HCPCS Codes for Portable Neuromodulation Stimulator (PoNS®) Mouthpiece and Controller

March 3, 2024

Helius Medical Technologies, Inc. Announces Alignment with FDA on Registrational Program for Treatment of Stroke Patients

February 5, 2024

Helius Booth and Special Event at APTA Combined Sections Meeting Will Highlight Physical Therapists’ Ability to Customize PoNS Therapy® to Improve Gait in People with MS

February 4, 2024

Helius Medical Technologies, Inc. Announces Further Expansion of Stroke Clinical Program with the Addition of Brooks Rehabilitation Hospital

January 10, 2024

Helius Medical Technologies to Present at NobleCon19 Annual Conference

November 29, 2023

Helius Medical Technologies, Inc. Reports Third Quarter 2023 Financial Results

November 8, 2023

Helius Medical Technologies, Inc. Announces Study Results Demonstrating That PoNS Therapy™ Helps Patients with Traumatic Brain Injury Return to Work

November 5, 2023

Helius Medical Technologies, Inc. to Release Third Quarter 2023 Financial Results on November 9, 2023; Announces Extended Cash Runway into Q2 2024

November 1, 2023

Helius Medical Technologies, Inc. Receives Letter of Intent from the Québec Ministry of Health and Social Services to Purchase 30 PoNS® Devices

October 11, 2023

Helius Medical Technologies to Participate at Two Upcoming Healthcare Conferences

October 1, 2023

Helius Medical Technologies, Inc. Receives UPC Numbers for its PoNS® System and Mouthpiece

September 27, 2023

Helius to Bring its Innovative PoNS Therapy for Improvement of Gait in People with MS, to the 2023 Academy of Neurologic Physical Therapy Conference

September 20, 2023

University of Montreal’s School of Rehabilitation to Purchase Ten PoNS® Devices for Research Study on Stroke Recovery

September 19, 2023

Helius Medical Technologies to Present at the 2023 Interdisciplinary Association of Functional Neuroscience and Rehabilitation Conference

September 12, 2023

Helius Medical Technologies, Inc. Compliant with All Applicable Nasdaq Listing Criteria

September 4, 2023

Helius Medical Technologies, Inc. Reports Second Quarter 2023 Financial Results

August 9, 2023

Helius Medical Technologies, Inc. Announces Participation of Montefiore Medical Center in its PoNS® Therapeutic Experience Program

August 6, 2023

Helius Medical Technologies, Inc. to Release Second Quarter 2023 Financial Results on August 10, 2023

August 1, 2023

Helius Medical Technologies, Inc. Expands Stroke Trial at the Medical University of South Carolina

July 26, 2023

Helius Medical Technologies Announces DMEPOS Accreditation for PoNS

June 19, 2023

Helius Medical Technologies to Participate in the Healthcare Virtual Conference Presented by Maxim Group LLC and hosted by M-Vest

June 13, 2023

Helius Medical Technologies to Present at LD Micro Invitational XIII 2023

May 24, 2023

Helius to Highlight Innovative PoNS Therapy™ at the 2023 Consortium of Multiple Sclerosis Centers Annual Meeting, in Commemoration of World MS Day

May 23, 2023

Helius Medical Technologies, Inc. Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

May 18, 2023

Helius Medical Technologies, Inc. Reports First Quarter 2023 Financial Results

May 10, 2023

Helius Medical Technologies, Inc. to Release First Quarter 2023 Financial Results on May 11, 2023

May 3, 2023

Helius Medical Technologies to Spotlight Expanded Authorizations for its PoNS Device at 2023 American Academy of Neurology Annual Meeting, Booth 1685

April 16, 2023

Helius Medical Technologies, Inc. Announces Distribution of Series B Preferred Stock to Holders of its Class A Common Stock Intended to Facilitate a Reverse Stock Split, if Necessary

March 22, 2023

Helius Medical Technologies and HealthTech Connex Announce Exclusive Distribution Agreement for the Portable Neuromodulation Stimulator (PoNS®) Device

March 21, 2023

Helius Medical Technologies, Inc. Reports Fourth Quarter and Full Year 2022 Financial Results

March 8, 2023

Helius Medical Technologies Announces Authorization from Health Canada to Market Portable Neuromodulation Stimulator (PoNS®) Device for the Treatment of Gait Deficit Due to Mild and Moderate Symptoms from Stroke

March 8, 2023

Helius Medical Technologies, Inc. to Release Fourth Quarter and Full Year 2022 Financial Results on March 9, 2023

March 5, 2023

Helius Medical Technologies to Present at the 35th Annual ROTH Conference

March 1, 2023

Helius Medical Technologies to Showcase PoNS Therapy™ at American Physical Therapy Association’s 2023 Combined Sections Meeting

February 14, 2023

Helius Medical Technologies, Inc. Announces Preliminary Results for the Fourth Quarter and Full Year 2022

January 22, 2023

Helius Medical Technologies to Present at the Virtual Q1 Investor Summit Microcap Event, January 26, 2023

January 18, 2023

Helius Medical Technologies, Inc. Announces Participation of Neurology Center of New England in its Therapeutic Experience Program

January 9, 2023

Helius Extends its Patient Therapy Access Program (PTAP), Bringing the Benefits of its PoNS® Device to More People with Multiple Sclerosis

January 4, 2023

Helius Launches UpScript Telehealth e-Commerce Site, Making it Easier for Americans with Multiple Sclerosis to Access Neurotech that can Improve their Ability to Walk

January 2, 2023

← Newer news releases · Older news releases →

Calls

The 5 newest of 15 calls. Every call is listed under its year.

Decks

The 5 newest of 17 decks. Every deck is listed under its year.